Viewing StudyNCT05062980



Ignite Creation Date: 2024-05-06 @ 4:42 PM
Last Modification Date: 2024-10-26 @ 2:14 PM
Study NCT ID: NCT05062980
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-26
First Post: 2021-09-20

Brief Title: Quaratusugene Ozeplasmid Reqorsa in Combination with Pembrolizumab in Previously Treated Non-Small Lung Cancer
Sponsor: Genprex Inc
Organization: Genprex Inc

Conditions & Keywords Data

Conditions:
Name
Non Small Cell Lung Cancer
Keywords:
Name View
quaratusugene ozeplasmid View
Tumor suppressor gene 2 TUSC2 View
Lipid nanoparticle LNP View
pembrolizumab View
Keytruda View
Gene therapy View
NSCLC View
docetaxel View
Reqorsa View
Acclaim-2 View